In this edition:

(Scroll down for more info and click on the links for additional details)

SAC 2023

Funding Opportunities:

• The Mark Foundation Emerging Leader Awards
• Lubin Family Foundation Scholar Award
• K12/Catalyst Medical Research Investigator Training Award
• Interim Support Funding 23-2
• ISCCCE Pilot Funding RFA
• Andrew L. Warshaw, M.D, Institute for Pancreatic Cancer Research
• Nurses’ Alumni Association (MGHNAA) Grant
• Limited Submission Funding Opportunities
• Foundation Funding Opportunities

Announcements:

• Postdoctoral Research Training Opportunity
• Consulting: NIH K Grant Specific Aims
• MGB Research Core NVivo Software
• Fundamentals of Drug Development at Mass General Brigham

Events:

• MGB World Medical Innovation Forum
• Virtual Research Tech Talk
• Women in Science Symposium
• Munn Nursing Research Grand Rounds
• MIT Hacking Medicine - Grand Hackathon
• MGH Midlife Women's Health Conference
• MGH Nursing Research Day Events
• The 24th Annual Harvard Nutrition Obesity Symposium
• Meditation Sessions available every week
• Fun Fridays
• 2023 Anne Klibanski Visiting Lecture Series 04
• Midlife Mayhem: Impact on Women at Work

SAC 2023

Wednesday, March 29 & Thursday March 30, 2023

This years meeting is in-person!

This year, MGH is holding their 73rd Scientific Advisory Committee (SAC) meeting on March 29 & 30, 2023. The theme of SAC this year will be The Adoption of Novel Technologies in the Practice of Medicine: Digital Health and AI.

Day 1, Wednesday, March 29, starts off with a virtual Scientific Poster Session that highlights the ongoing research at MGH. This will be followed by a Celebration of Science at the Simches Research Center Auditorium, room 3.110. During this time, we will present awards for the 2023 Martin Prizes and the 2023 Goodman Fellowship. We will also be announcing the 2023 Research Scholars.

Day 2, Thursday, March 30, will also take place in the Simches Research Center Auditorium, room 3.110. We will begin with a morning session that focuses on The Power of AI to Transform Health Care. The afternoon session will focus on real word examples and also Novel Technologies.

The Mark Foundation Emerging Leader Awards

The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.

The grant amount: $250,000 per year for three (3) years totaling $750,000.

Indirect costs are not to exceed 10% of direct costs and are included in total.

Applications are due: 5 PM Eastern Time on Monday, May 1, 2023.

Lubin Family Foundation Scholar Award

Application Deadline: May 5th, 2023 by 5pm

Award Amount: $150,000 per year for 4 years

Key Eligibility: Researchers who work at eligible institutions which include applicants from Dana‑Farber, other Dana‑Farber/Harvard Cancer Center affiliated institutions (BIDMC, BCH, BWH, HMS, HSPH, MGH, MIT/WI/KI, Broad Institute). Applicants must be MD or MD/PhD fellows or Category 4 Instructors (or equivalent appointment at the applicant’s institution) who have completed no less than 18 months, and no more than 36 months, of laboratory research on July 3, 2023. See RFA for additional criteria.

K12/Catalyst Medical Research Investigator Training Award

The K12/CMeRIT program offers advanced training through educational activities and mentored research for senior fellows and junior faculty in clinical and translational research. The award provides two years of salary support at 50-75% of the awardee’s institutional salary base within NIH guidelines. Please see the website for application instructions and detailed eligibility requirements.

The application opens March 9 and is due May 26.

Contact us is you have questions. 

INTERIM SUPPORT FUNDING 23-2

Interim Support Funding

The Interim Support Funding (ISF) Program is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense). Investigators must have applied for independent, long-term support (R01, R21, U01 and P01). The intent of the program is to rescue strong scientific programs that are in need of bridge funding in order to sustain their research. Applications will be accepted regardless of percentile or score, including applications that were not discussed.

When is the deadline?

Monday, April 3, 2023 - 5:00 PM

NEW ISCCCE Pilot Funding RFA: Implementation Science Pilot Grants



The Implementation Science Center for Cancer Control Equity (ISCCCE) is excited to share the release of a new Request for Applications for Pilot Grants on implementation research on health equity in community settings. Up to $75,000 for 1 year to support the planning of a new clinical, community, or policy implementation science research project. Letters of Intent are due April 10, 2023.

ISCCCE leadership will host an orientation webinar to share more about the center’s infrastructure, existing pilots, and answer any questions about the RFA on March 9th from 3-4pm (no registration required, attendance is strongly encouraged). As part of the grant application process, we will also offer Community Engagement Studios to provided applicants with direct feedback and guidance on their research concepts via a facilitated conversation with community health center partners.

2023 Request for Applications: Andrew L. Warshaw, M.D, Institute for Pancreatic Cancer Research

Submission Deadline: Wednesday, April 12, 2023, 5:00PM

The Andrew L. Warshaw, M.D., Institute for Pancreatic Cancer Research is pleased to announce the 2023 call for applications for $60,000 pilot awards for MGH Investigators. Applications are welcome from new investigators, established investigators in the field of pancreatic cancer, as well as senior investigators who have not previously worked in this area. The Institute is particularly interested in research directed towards identifying specific causes of pancreatic cancer; early detection, understanding factors that promote tumor growth; novel imaging modalities; understanding mechanisms of resistance to existing chemotherapy and radiation, as well as exploring novel therapeutic approaches. Basic, translational, and clinical research projects will be considered.

Pilot Awards: Up to three pilot grants will be funded for one year at $60,000 (direct costs).

The Massachusetts General Hospital Nurses’ Alumni Association (MGHNAA) Grant

The MGHNAA grant is supported and named for the Alumni Association of the MGH School of Nursing (1873-1981) whose mission is to support nursing education, professional development, research, community engagement and to record and maintain the history of nursing at Massachusetts General Hospital. The MGHNAA is a 2-year grant that offers a Doctor of Nursing Practice program or an advanced practice nurse graduate of a Master of Science in Nursing program the opportunity to lead a clinically-relevant EBP, Quality Improvement, or Original Research project. The project should aim to advance nursing science and improve outcomes for nursing workforce, patients, or families. The grant provides up to $3000 for project related expenses.

Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination. 

CURRENT OPPORTUNITIES:

See full details for all awards on our website.

Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. 

Learn more

Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to resources provided by the Data Management Coordinating Center for Diagnostic Centers of Excellence (RFA-NS-22-051), as part of the next phase of the Undiagnosed Diseases Network.

Learn more

Alliance for Innovation on Maternal Health (AIM) Capacity – NEW!

This notice announces the opportunity to apply for funding under the Alliance for Innovation on Maternal Health (AIM) Capacity program. The AIM program is the national, cross-sector commitment designed to lead in the identification, development, implementation, and dissemination of maternal (patient) safety bundles for the promotion of safe care for every U.S. birth and assist with addressing the complex problem of high maternal mortality and SMM rates within the United States. 

Learn more

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 – Independent Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

Learn more

Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Clinical Research Centers (CRC) for the NIAID Consortium for Food Allergy Research (CoFAR). 

Learn more

Consortium for Food Allergy Research: Leadership Center (UM1 Clinical Trial Required)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Leadership Center of the NIAID Consortium for Food Allergy Research (CoFAR).

Learn more

Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (R24 Clinical Trial Not Allowed)

The Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) program will advance infectious disease modeling science by serving as a hub for collaboration and dissemination of research products from the MIDAS investigator network. 

Learn more

Population Dynamics Centers Research Infrastructure Program FY 2024 (P2C Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

Learn more

Postbaccalaureate Research Education Program in Diabetes, Endocrinology, and Metabolic Diseases (R25 – Independent Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. 

Learn more

Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.



CURRENT OPPORTUNITIES:

See full details for all awards on our website.

NEW! Imaging Research in Alzheimer’s and Other Neurodegenerative Diseases, Alzheimer's Association (ALZ). $200,000. LOI Deadline: June 5

Career Development Award (CDA), American Academy of Neurology (AAN). $450,000. Application Deadline: September 14

Clinical Research Training Scholarship (CRTS) (multiple opps), American Academy of Neurology (AAN). $150,000. Application Deadline: September 14

Neuroscience Research Training Scholarship (NRTS), American Academy of Neurology (AAN). $150,000. Application Deadline: September 14

Practice Research Training Scholarship, American Academy of Neurology (AAN). $150,000. Application Deadline: September 14

Richard Olney Clinician Scientist Development Award in ALS, American Academy of Neurology (AAN). $240,000. Application Deadline: September 14

AACR-Novocure Cancer Research Grant, American Association for Cancer Research (AACR). $350,000. LOI Deadline: May 30

AACR-Novocure Career Development Award, American Association for Cancer Research (AACR). $300,000. LOI Deadline: May 30

ACS Research Priority Area: Screening (multiple opps), American Cancer Society (ACS). $1.2 million. Application Deadline: April 3

NEW! AHA's Second Century Clinical Fellow Research Education Program, American Heart Association (AHA). $52,500. Application Deadline: April 13

NEW! AHA's Second Century Early Faculty Independence Award, American Heart Association (AHA). $300,000. Preproposal Deadline: April 4

ASH Bridge Grant Program, American Society of Hematology (ASH). $150,000. Application Deadline: May 1

Fellowship Research Award, American Surgical Association Foundation (ASAF). $150,000. Application Deadline: June 15

Seed Grants, Amyotrophic Lateral Sclerosis Association. $50,000. LOI Deadline: April 25

Special Initiatives Pilot Funding, Blue Cross Blue Shield of Massachusetts (BCBSMA) Foundation. $50,000. Proposal Deadline: September 11

Alan and Helene Goldberg In Vitro Toxicology Grants, Johns Hopkins Center for Alternatives to Animal Testing (CAAT). $40,000. Preliminary Proposal Deadline: April 30

Ben Barres Early Career Acceleration Award, Chan Zuckerberg Initiative. $1.2 million. LOI Deadline: April 20

Annual Community Impact Grants Program, Fallon Health. $45,000. LOI Deadline: April 30

Action Potential Grant, FamilieSCN2A Foundation. $50,000. LOI Deadline: April 1

Early-Stage Research Grants, Gastric Cancer Foundation. $100,000. LOI Deadline: March 31

NEW! Huntington's Disease (HD) Transformative Research Award Program, Hereditary Disease Foundation. $1 million. LOI Deadline: April 15

Lymphangioleiomyomatosis Grant Opportunities (multiple opps), LAM Foundation. $180,000. LOI Deadline: June 15

NEW! LCRF – Daiichi Sankyo – AstraZeneca Research Grant on Antibody Drug Conjugates, Lung Cancer Research Foundation (LCRF). $270,000. Application Deadline: May 31

Research Grant Program, Mendez National Institute of Transplantation Foundation (MNITF). $100,000. LOI Deadline: June 15

Research Grants (multiple opps), National Eczema Association (NEA). $150,000. Application Deadline: July 31

Do you want to learn more about identifying external funding opportunities? Please click here to request a research consultation with Amy Robb or see ECOR’s website for information on the Pivot database.

Postdoctoral Research Training Opportunity

Program Overview

Bridging the Science-to-Service Gap: Prevention, Optimization and Living Well with Persistent or Serious Illness (Bridge-The-Gap) is funded by a T32 training grant award from the National Institute on Aging. It is focused on training scientists to conduct clinical and behavioral prevention interventions across the continuum from health to illness across all care settings (hospital, nursing homes) and in the community for older individuals or those with persistent or serious illness, and their care-partners. Fellowships are 1-3 years in duration.

Consulting: NIH K Grant Specific Aims 

NIH K grant applicants, apply to have the specific aims section of your grant reviewed by Harvard faculty who have successfully received NIH grant funding. Offered by our Writing and Communication Center, this free service for Harvard-affiliated researchers is currently accepting consultation applications on a rolling basis. 

Please note, consultations will occur remotely and a limited number of consultations will be offered.

MGB Research Core NVivo Software

Time to renew your NVivo portal license through the ERIS Research Computing Core. Annual NVivo licenses expire each year on February 28th. Your license will automatically cancel, and you will need to order again at rcservices.partners.org (MGB login required). Nvivo licenses are $350/year per User and new licenses can be ordered and accessed today.



NVivo is software that can be used for qualitative analysis of textual and audiovisual data sources. NVivo portal licenses require no installation and you may log into your account on any computer, to access the NVivo portal. For more information on NVivo go to the Research Computing Core's software page or order now at rcservices.partners.org (MGB login required). All questions may be directed to rcc@partners.org.

Fundamentals of Drug Development at Mass General Brigham

On-Demand Innovation Education: MESH Core Healthcare Innovation Bootcamp

What is the process involved in taking a new drug from the laboratory to market? What are the barriers and logistical challenges along the way? In this session, Dione Kobayashi, PhD, Head of Therapeutics and Operating Partner with Amplify, will discuss the factors driving successful drug development and outline approaches that may be applied in an academic setting including the Amplify translational technology program.

MGB World Medical Innovation Forum

June 12-14, 2023

Boston's Top Healthcare Innovation Gathering

Join leading healthcare and financial experts at the World Medical Innovation Forum as they assess the impact of the latest innovations in three of today’s fastest breakthrough areas.

Network with industry disruptors and executives, including top Harvard clinicians and scientists from Mass General Brigham, the premier academic research organization and medical system in the U.S., and financial experts from Bank of America, manager of one of the largest healthcare portfolios in the industry.

The next virtual Research Tech Talk is Thursday March 30th, 2023 - 12:00pm to 2:00pm.  

Sofia Dmitriev, MGB’s RISC Cloud Data Solutions Assistant Director, will present “The Complete PDSR Curated Data Set”. This remarkably large data repository provides the research community the opportunity to access and analyze over 5 billion observation facts on the entire Mass General Brigham patient population using data science tools within the highly secure ecosystem MGB Analytics Enclave.



Jonathan Hamill, PhD, Cloud Architect, MGB Digital-ERIS, will give a comprehensive update on current cloud offerings available to research and will discuss upcoming offerings and initiatives.  

MIT Hacking Medicine - Grand Hackathon



Tackle healthcare’s toughest pain points alongside healthcare professionals, designers, engineers, and entrepreneurs. Participants of any background with a passion for healthcare are welcome! With 400+ participants and multiple healthcare tracks, there’s a challenge for everyone.

Where is MIT Grand Hack?

MIT Hacking Medicine is excited to bring you the 2023 MIT Grand Hack on April 20-23rd, in Cambridge, MA.

MGH Midlife Women's Health Conference

May 12, 2023

Midlife Women’s Health 2023 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise. CME will be offered for this conference.

MGH Nursing Research Day Events

Calling ALL Nurses! A Celebration of Practice Nurse’s Scholarship: MGH Nursing Research Day Poster Award Winner Presentations

Tuesday May 16^th 1:30-2:30-Virtual Presentation

Support and cheer on your colleagues as they present their award winning projects! Learn how to access and review over 40 virtual EBP, QI and research projects conducted by YOUR fellow nurse colleagues from MGH and affiliates! 

MGH Nursing Research Day: Learn How Our Nurses Transform Cutting Edge Practice into Scholarship to Improve Outcomes

Thursday May 18^th 1:30-3:00-Hybrid Presentation

Come in person to the O’Keeffe Auditorium to celebrate and hear updates from the MGH Munn Center, the announcement of the 2023 Nursing Grant Award Recipients,

and learn about fun initiatives for ALL Nurses!

Featured Invited Presenter: 

Angelleen Peters-Lewis, PhD, RN, FAAN

Vice President, Chief Operating Officer

Barnes-Jewish Hospital

Presentation title: “The Power of Nursing: Pathways and Possibilities.”

Program details and registration information are forthcoming. We hope to see everyone!

The Munn Center munncenter@partners.org

The 24^th Annual Harvard Nutrition Obesity Symposium – Adiposity, Immunity, and Inflammation: Interrelationships in Health and Disease

Date: June 7, 2023

Time: 8:30am to 4:30pm EST 

The Nutrition Obesity Research Center at Harvard (NORCH) invites you to attend our 24th Annual Symposium, featuring the latest research on a wide range of topics including nutritional regulation of immunity, immunometabolic drivers of heart failure, and immunological landscape of adipose tissue. The George L. Blackburn Keynote Lecture, "Obesity and Immunometabolism," will be given by Dr. Lydia Lynch of Harvard University School of Medicine.

Additional event info and speaker information can be found here.

This event will be held virtually. All are welcome!

Registration is free for all attendees. Register now

Two Meditation Sessions available every week



SESSION 1: Meditation Mondays with Dr. Darshan Mehta 

Every Monday, 8:00 – 8:30 am, Zoom à next session, Monday, March 27!

Co-sponsored by the Center for Faculty Development’s Office for Well-Being and the MGPO Frigoletto Committee

Join Darshan Mehta, MD, MPH, Director, Office for Well-Being, for a guided meditation session on Monday morning. 

Register and add to calendar

SESSION 2: Midweek Meditation with Guest Leader 

Every Wednesday, 8:00 – 8:30 am, Zoom à next session, Wednesday, March 29!

Sponsored by the Center for Faculty Development’s Office for Well-Being

Join guest leader, Paula McCree, MGH Heart Center, for next Wednesday’s guided meditation session on March 29^th!

Register and add to calendar

Fun Fridays- Journaling with Olga – Catching Fireflies

Friday, March 24, 2023, 12:00 – 1:00 pm, Zoom

Sponsored by the Center for Faculty Development’s Office for Well-Being

Fun Fridays offer a refreshing mid-day break from work to indulge in physical, mental, or creative activity.

Join Olga for a fun hour of journaling activities designed to free your creative spirit and improve your self-care through writing. In this session, we will practice writing prompts to learn more about ourselves, drawing inspiration from Joe Brainard’s “I Remember” memoir. Memories are like fireflies flickering in the dark, only the brightest ones are noticed.

Playwright Tennessee Williams once asked: “Has it ever struck you that life is all memory, except for the one present moment that goes by so quick you hardly catch it going?” Join us for a cathartic writing session. Journaling is a private art form and sharing is optional.

Instructor: Olga Katsovskiy, MHA, is a Program Manager in the Endocrine Unit at MGH. In addition, she is a Writing Instructor at the Cambridge Center for Adult Education. She enjoys reading and writing nonfiction, and is devoted to daily journaling, obscure books, and good coffee.

Click to register

2023 Anne Klibanski Visiting Lecture Series 04

Tuesday, March 28, 2023, 12:00 - 1:00 pm, Zoom

Provided by: MGH Center for Faculty Development & Mass General Brigham

"Challenges in Performing Research in Patients with Peripheral Vascular Disease"

The Anne Klibanski Visiting Lecture Series was created to support and advance the careers of women. These lectures offer the opportunity for women faculty from outside institutions that have hosted Anne Klibanski Scholars to present on their expertise, either alone or in tandem with an Anne Klibanski Scholar. 

Learning Objectives:

Upon completion of this activity, participants will be able to:

·       Examine challenges in enrolling diverse patients with peripheral arterial disease (PAD).

·       Examine recent clinical trials/registries in patients with PAD and the need for diverse patient enrollment.

·       Identify several potential solutions for enrolling underrepresented minorities and women into registries/clinical trials of patients with PAD.

Target Audience: This activity is intended for faculty and faculty trainees.

Course Director: Miriam A. Bredella, MD, MBA, Director, Center for Faculty Development; Professor of Radiology, Harvard Medical School

Presenter: Jennifer Rymer, MD, interventional cardiologist and John Bush Simpson Assistant Professor of Medicine at Duke University

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Click to register

Midlife Mayhem: Impact on Women at Work

Friday, March 31, 2023, 12:00 – 1:00 pm, Zoom 

Sponsored by the Center for Faculty Development’s Office for Women’s Careers

During this interactive webinar, Dr. Jan Shifren and Jannine Versi will discuss symptoms of the menopausal transition and their potential impact on women at work.

Discussion Facilitators:

Jan Shifren, MD, is a gynecologist, reproductive endocrinologist, and director of the Mass General Midlife Women’s Health Center. Dr. Shifren’s research focuses on menopause, including the effects of estrogens, androgens, and alternative therapies on menopausal symptoms, mood, and sexual function. She has authored many articles and book chapters, and has delivered national and international presentations on menopause, hormone therapy, androgens for women, the genitourinary syndrome of menopause, and female sexual function. She is past president of the North American Menopause Society.

Jannine Versi is the Co-founder & COO of Elektra Health, an organization on a mission to smash the menopause taboo.

Click to register